CTI BioPharma Corp. (CTIC)

0.33
0.01 4.40
NASDAQ
Prev Close 0.32
Open 0.34
Day Low/High 0.33 / 0.34
52 Wk Low/High 0.25 / 1.94
Volume 1.34M
Exchange NASDAQ
Shares Outstanding 282.81B
Market Cap 99.55M
Div & Yield N.A. (N.A)

Latest News

CTI BioPharma Announces Presentations At The American Society Of Clinical Oncology Annual Meeting

CTI BioPharma Announces Presentations At The American Society Of Clinical Oncology Annual Meeting

- Four abstracts selected to be presented on pacritinib highlighting additional safety and long-term follow up data from Phase 3 PERSIST-1 trial -

CTI BioPharma Announces Presentations At The American Association Of Cancer Research Annual Meeting

CTI BioPharma Announces Presentations At The American Association Of Cancer Research Annual Meeting

- Five abstracts selected to be presented on pacritinib -

UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders Of CTI BioPharma Corp. Of Class Action And A Lead Plaintiff Deadline Of April 11, 2016

UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders Of CTI BioPharma Corp. Of Class Action And A Lead Plaintiff Deadline Of April 11, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of CTI BioPharma Corp.

April 11 Deadline Alert: Law Offices Of Howard G. Smith Reminds CTI BioPharma Corp. Investors Of Upcoming Lead Plaintiff Deadline

April 11 Deadline Alert: Law Offices Of Howard G. Smith Reminds CTI BioPharma Corp. Investors Of Upcoming Lead Plaintiff Deadline

Law Offices of Howard G. Smith reminds investors of the upcoming  April 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased CTI BioPharma Corp.

Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders

Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders

Stocks with insider trader activity include SPTN, FL and CTIC

Insider Trading Alert - ATRS, CMT And CTIC Traded By Insiders

Insider Trading Alert - ATRS, CMT And CTIC Traded By Insiders

Stocks with insider trader activity include ATRS, CMT and CTIC

Insider Trading Alert - DRE And CTIC Traded By Insiders

Insider Trading Alert - DRE And CTIC Traded By Insiders

Stocks with insider trader activity include DRE, CTIC and WAFD

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of CTI BioPharma Corp. Investors

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of CTI BioPharma Corp. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased CTI BioPharma Corp.

STOCK ALERT: Rosen Law Firm Reminds CTI BioPharma Corp. Investors Of Important Deadline In Class Action - CTIC

STOCK ALERT: Rosen Law Firm Reminds CTI BioPharma Corp. Investors Of Important Deadline In Class Action - CTIC

Rosen Law Firm, a global investor rights law firm, reminds purchasers of CTI BioPharma Corp.

CTI BioPharma Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

CTI BioPharma Corp. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold for Himself

Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold for Himself

In the latest blowup, excess patient deaths forced CTI Bio to yank a new drug application for the myelofibrosis drug pacritinib.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CTI BioPharma Corp. - CTIC

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CTI BioPharma Corp. - CTIC

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of CTI BioPharma Corp.

Kirby McInerney LLP Advises CTI BioPharma Corp. Investors Of Potential Claims

Kirby McInerney LLP Advises CTI BioPharma Corp. Investors Of Potential Claims

The law firm of Kirby McInerney LLP announced today that it has been retained by an investor to pursue claims against CTI BioPharma Corp.

3 Big Stocks You Should Stay Away From Right Now

3 Big Stocks You Should Stay Away From Right Now

Here's a technical look at how to trade some of the most active stocks on Wall Street right now.

INVESTOR ALERT: Investigation Of CTI BioPharma Corp. Announced By Law Offices Of Howard G. Smith

INVESTOR ALERT: Investigation Of CTI BioPharma Corp. Announced By Law Offices Of Howard G. Smith

Law Offices of Howard G. Smith announces an investigation on behalf of investors of CTI BioPharma Corp.

CTI BioPharma Provides Update On Investigational Agent Pacritinib

CTI BioPharma Provides Update On Investigational Agent Pacritinib

FDA Places Partial Clinical Hold on Pacritinib IND; Currently Enrolled Patients Benefiting from Pacritinib Can Continue Receiving Pacritinib

3 Biotech Stocks Under $10 to Trade for Big Breakouts

3 Biotech Stocks Under $10 to Trade for Big Breakouts

These biotech stocks trading for less than $10 a share are within range of triggering breakout trades.